検索タンパク質、抗体、アッセイキット
タンパク質カタログ
輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。
- サプライヤー
- TargteMol
- カタログNo.
- TMPY-00949
- 製品名称
- VEGFR3/FLT4 Protein, Human, Recombinant (His)
- タンパク質名
- VEGFR3/FLT4
- Species
- Human
- HOST
- HEK293 Cells
- 100μg: -
- お問い合わせ
Overview
| Synonyms | VEGFR-3, PCL, FLT41, VEGF Receptor 3, VEGFR3, FLT-4, fms related tyrosine kinase 4, LMPH1A, FLT-41 |
|---|---|
| Characteristics | 1. Measured by its binding ability in a functional ELISA. 2. Immobilized human VEGF-C at 10 μg/mL (100 μl/well) can bind human VEGFR3-his. The EC50 of human VEGFR3-his is 0.011 μg/mL. |
| Endotoxin Level | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Purity | 96.70% |
| Description | VEGFR3/FLT4 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86 kDa and the accession number is P35916-1. |
| Reference | Stearns ME,et al.(2004) Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis. Lab Invest. 84(6): 785-95.,Iljin K,et al.(2001) VEGFR3 gene structure, regulatory region, and sequence polymorphisms. FASEB J. 15(6): 1028-36.,Shushanov S,et al.(2000)VEGFc and VEGFR3 expression in human thyroid pathologies. Int J Cancer.86(1): 47-52.,Liu XE,et al.(2004) Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol. 10(3): 352-5. |
| URL | https://www.targetmol.com/recombinant-protein/vegfr3_flt4_protein_human_recombinant_his_tag_hplc_verified |
お問い合わせリスト